Financials
- Fiscal year
- 2024
- Total assets
- €339,852
- Profit
- €4,292
- Solvency
- 9.5%
Total assets▲ 42.3%
Net result
20202024
GINGENROOTS
ActiveThe file of GINGENROOTS contains 3 judicial reorganisation notices, as published in the Belgian State Gazette.
Summary
The computed 12-month bankruptcy probability is ≥ 25% (high). The 2024 annual accounts show equity of €32,378 and a net result of €4,292. Equity is growing by ~107.4% per year across the filed fiscal years. Its solvency ranks better than 30% of 26069 sector peers (fiscal year 2024).
Overview
Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
NACE 47741NACE 47740
1 site
Size
€339,852total assets 2024
- Equity
- €32,378
- Profit
- €4,292
Turnover not published (abridged schema)
Structure
Accounts 66 d overdue0 of 8 deeds read
Why 12- Reorganisation plan being carried out (approved, Gazette 19-05-2026)- 1 financial year not filed after the legal deadline; latest accounts 61 days late; 2 of the last 3 late- Figures for FY 2024 (filed 30-09-2025)- 3 warning signals in 24 months (reorganisation 3)Show the evidence
Checked score
Score 2024
12
/ 100
Critical
Probability in this band: over 15.0%
Better than 38% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2023
Weak
Solvency
35-2
equity 9.5% of total assets
Liquidity
3-2
short-term debt 90.5% · cash 2.4%
Profitability
70-9
return on assets 1.3%
Bankruptcy probability, 12 months
≥ 25%
High
0%0.5%1.5%4%10%≥ 25%
About 1 in 4 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 15.3%
12-2024: 16.7%▲ +9.1% vs 11-2024
01-2025: 19.3%▲ +16.0% vs 12-2024
02-2025: 19.3%● 0.0% vs 01-2025
03-2025: 16.1%▼ -16.9% vs 02-2025
04-2025: 16.4%▲ +1.7% vs 03-2025
05-2025: 16.5%▲ +0.7% vs 04-2025
06-2025: 16.4%▼ -0.7% vs 05-2025
07-2025: 16.1%▼ -1.7% vs 06-2025
08-2025: 10.9%▼ -32.2% vs 07-2025
09-2025: 11.9%▲ +8.8% vs 08-2025
10-2025: 4.6%▼ -61.4% vs 09-2025
11-2025: 2.9%▼ -35.9% vs 10-2025
12-2025: 2.9%● 0.0% vs 11-2025
01-2026: 2.9%▼ -2.0% vs 12-2025lowest value
06-2026: 17.7%
07-2026: 17.5%▼ -0.7% vs 06-2026
08-2026: 20.5%▲ +16.8% vs 07-2026
09-2026: 21.1%▲ +3.1% vs 08-2026
10-2026: ≥ 25%▲ +28.8% vs 09-2026highest value
- Reorganisation plan being carried out (approved, Gazette 19-05-2026) raises the probability
- 1 financial year not filed after the legal deadline; latest accounts 61 days late; 2 of the last 3 late raises the probability
- Figures for FY 2024 (filed 30-09-2025) raises the probability
- 3 warning signals in 24 months (reorganisation 3) raises the probability
No credit on open account
Liquidity tight (current ratio 1.07 against 1.06 in 2023; short-term debt: 90.5% and cash: 2.4% of total assets), and 90.5% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 26%, liquidity 5%, profitability 52%, growth against the median 68%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 04-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
+raises risk○neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 5 filingsDeviation from the deadline
2025
not confirmed
2024
61 d late
2023
188 d late
2022
47 d early
2021
124 d late
2020
489 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 5 accounts on average 163 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (1)
- Plan homologationTribunal de l’entreprise francophone de…
- ExtensionTribunal de l’entreprise francophone de…
- OpeningTribunal de l’entreprise francophone de…
Key points
By topic
Timeline
- Events
- 11
- Since
- 2022
- 19-05-2026Plan homologation
- 10-04-2026Extension
- 22-01-2026Opening
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of medical and orthopaedic goods, excluding…NACE 47741
- Founded
- 02-12-2019
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.